AAAAAA
Results:
1-19
|
Results: 19
Authors:
Sarno, M
Sarno, L
Baylink, D
Drinkwater, B
Farley, S
Kleerekoper, M
Lang, R
Lappe, J
Licata, A
McClung, M
Miller, P
Nattrass, S
Recker, R
Schwartz, EN
Tucci, JR
Wolf, S
Powell, H
Tjersland, G
Warnick, GR
Citation: M. Sarno et al., Excretion of sweat and urine pyridinoline crosslinks in healthy controls and subjects with established metabolic bone disease, CLIN CH L M, 39(3), 2001, pp. 223-228
Authors:
Drake, WM
McClung, M
Njeh, CF
Genant, HK
Rosen, C
Watts, N
Kendler, DL
Citation: Wm. Drake et al., Multisite bone ultrasound measurement on North American female reference population, J CLIN DENS, 4(3), 2001, pp. 239-248
Authors:
Njeh, CF
Saeed, I
Grigorian, M
Kendler, DL
Fan, B
Shepherd, J
McClung, M
Drake, WM
Genant, HK
Citation: Cf. Njeh et al., Assessment of bone status using speed of sound at multiple anatomical sites, ULTRASOUN M, 27(10), 2001, pp. 1337-1345
Authors:
Orloff, C
Vaughan, T
McClung, M
Seyl, S
Seidmann, R
Livingston, K
Anoushiravani, M
Cooper, G
Friedenwald-Fishman, E
Glass, C
Sinclair, B
Citation: C. Orloff et al., A tribute to Terence Edward O'Donnell, October 21, 1924-March 12, 2001, OREG HIST Q, 102(2), 2001, pp. 229-240
Authors:
McClung, B
McClung, M
Citation: B. Mcclung et M. Mcclung, Pharmacologic therapy for the treatment and prevention of osteoporosis, NURS CLIN N, 36(3), 2001, pp. 433
Authors:
McClung, M
Citation: M. Mcclung, The effect of risedronate on the risk of hip fracture in elderly women. Reply, N ENG J MED, 344(22), 2001, pp. 1721-1721
Authors:
Murphy, MG
Weiss, S
McClung, M
Schnitzer, T
Cerchio, K
Connor, J
Krupa, D
Gertz, BJ
Citation: Mg. Murphy et al., Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women, J CLIN END, 86(3), 2001, pp. 1116-1125
Authors:
Gallagher, JC
Baylink, DJ
Freeman, R
McClung, M
Citation: Jc. Gallagher et al., Prevention of bone loss with tibolone in postmenopausal women: Results of two randomized, double-blind, placebo-controlled, dose-finding studies, J CLIN END, 86(10), 2001, pp. 4717-4726
Authors:
Hla, MM
Davis, JW
Ross, PD
Yates, J
Wasnich, RD
Ravn, P
McClung, M
Hosking, D
Citation: Mm. Hla et al., Relation between body composition and biochemical markers of bone turnoveramong early postmenopausal women, J CLIN DENS, 3(4), 2000, pp. 365-371
Authors:
Schnitzer, T
Bone, HG
Crepaldi, G
Adami, S
McClung, M
Kiel, D
Felsenberg, D
Recker, RR
Tonino, RP
Roux, C
Pinchera, A
Foldes, AJ
Greenspan, SL
Levine, MA
Emkey, R
Santora, AC
Kaur, A
Thompson, DE
Yates, J
Orloff, JJ
Citation: T. Schnitzer et al., Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis, AGING-CLIN, 12(1), 2000, pp. 1-12
Authors:
McClung, M
Citation: M. Mcclung, Assessing bone mass by X-ray absorptiometry: The WHO definition of osteoporosis, MANAGEMENT OF FRACTURES IN SEVERELY OSTEOPOROTIC BONE, 2000, pp. 33-43
Authors:
McClung, M
Citation: M. Mcclung, Results of special studies with alendronate, INT J CL PR, 1999, pp. 67-72
Authors:
Ravn, P
Cizza, G
Bjarnason, NH
Thompson, D
Daley, M
Wasnich, RD
McClung, M
Hosking, D
Yates, AJ
Christiansen, C
Citation: P. Ravn et al., Low body mass index is an important risk factor for low bone mass and increased bone loss in early postmenopausal women, J BONE MIN, 14(9), 1999, pp. 1622-1627
Authors:
Kleerekoper, M
Deftos, L
Khosla, S
Maricic, M
McClung, M
Rosen, C
Shane, E
Citation: M. Kleerekoper et al., Osteology: Further debate - Reply, J BONE MIN, 14(6), 1999, pp. 1017-1017
Authors:
McCloskey, EV
Bone, H
Rodan, G
McClung, M
Wallach, S
Lyles, KW
Grauer, A
Mautelan, C
Gutteridge, DH",Anderson,Hooper,Ralston,Sharpe,Posen
Citation: Ev. Mccloskey et al., Newer bisphosphonates in the treatment of Paget's disease of bone: Where we are and where we want to go - Discussion, J BONE MIN, 14, 1999, pp. 74-78
Authors:
Ravn, P
Hosking, D
Thompson, D
Cizza, G
Wasnich, RD
McClung, M
Yates, AJ
Bjarnason, NH
Christiansen, C
Citation: P. Ravn et al., Monitoring of alendronate treatment and prediction of effect on bone mass by biochemical markers in the early postmenopausal intervention cohort study, J CLIN END, 84(7), 1999, pp. 2363-2368
Authors:
McClung, M
Arce, JC
Citation: M. Mcclung et Jc. Arce, Total hip bone mineral density changes with several doses of 17 beta-estradiol and continuous combined 17 beta-estradiol and norethindrone acetate, 9TH INTERNATIONAL MENOPAUSE SOCIETY WORLD CONGRESS ON THE MENOPAUSE, 1999, pp. 105-108
Authors:
Lundquist, M
Daggett, SC
McClung, M
Gorman, PC
Citation: M. Lundquist et al., Section 4: Technical infrastructure of the electronic library, LIB HI TECH, 16(3-4), 1998, pp. 110-124
Authors:
Lundquist, M
McClung, M
Riley, C
Citation: M. Lundquist et al., Section 5: Electronic library production support: The library technology group help desk, LIB HI TECH, 16(3-4), 1998, pp. 125-131
Risultati:
1-19
|